OBB Newsletter

  • Enter your e-mail address below to subscribe to the Orange Book Blog newsletter. If a new post is added during the day, you'll receive it by e-mail the next morning.

Enter your email address:

Delivered by FeedBurner

AddThis Feed Button

Disclaimer

  • Orange Book Blog is published for informational purposes only; it contains no legal advice whatsoever. Publication of Orange Book Blog does not create an attorney-client relationship. Orange Book Blog is Aaron Barkoff's personal website and it is intended primarily for other attorneys. Orange Book Blog is not edited by McDonnell Boehnen Hulbert & Berghoff LLP ("MBHB") or its clients. Therefore, no part of Orange Book Blog--whether information, commentary, or other--may be attributed to MBHB or its clients. Readers should be aware that MBHB represents many companies in the pharmaceutical and biotechnology industries, and therefore Orange Book Blog may occasionally report on news that relates to MBHB clients. Orange Book Blog will always strive to be unbiased in its reporting. All information on Orange Book Blog should be double-checked for its accuracy and current applicability. -- © Aaron F. Barkoff 2006-08

« Pharma News Briefs | Main | FTC Pursues Antitrust Case Against Barr Labs After District Court Denies Barr's Motion to Dismiss »

February 06, 2007

ACI "FDA Boot Camp" Conference, March 26-27, NYC

American Conference Institute has announced that its third FDA Boot Camp will be taking place March 26-27, 2007, in New York, New York.  According to ACI, the inaugural FDA Boot Camp conference, held in New York last March, was sold out, as was this past September’s FDA Boot Camp in Chicago.  Designed for product liability and patent litigators, as well as patent prosecutors and life sciences investment/securities experts, the conference promises to provide attendees with a strong working knowledge of core FDA regulatory competencies.

ACI has assembled a distinguished faculty of top FDA regulatory experts that will share their knowledge and give critical insight on such topics as the organization, functions, and operations of the FDA; essentials of the approval process for drugs, biologics and devices, including NDAs, INDs and BLAs; and clinical trials for drugs and biologics and the clearance process for devices.  Demand for this conference is high and ACI expects another sell out; early registrations are recommended.  For more information on the event, visit ACI's FDA Boot Camp web site: www.americanconference.com/fdabootcampnyc.

Orange Book Blog is a media partner of this conference.

Comments

Post a comment

Comments are moderated, and will not appear on this weblog until the author has approved them.